Alembic Pharmaceuticals Faces Mixed Performance Amid Broader Market Trends

Alembic Pharmaceuticals has experienced a notable decline of 3.58% on May 20, 2025, underperforming the broader sector by 3.65%. The stock reached an intraday low of Rs 989, reflecting a drop of 3.82%. Despite this downturn, Alembic's moving averages indicate that its performance is higher than the 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average.
In the broader market context, the Sensex opened flat with a slight change of 56.75 points, currently trading at 82,051.32, down 0.01%. The index is nearing its 52-week high, just 4.79% away from 85,978.25. While the Sensex is above its 50-day moving average, the 50-day moving average itself is below the 200-day moving average.

Over various time frames, Alembic Pharmaceuticals has shown mixed performance. In the past week, the stock has gained 10.69%, while its one-month performance stands at 16.06%. However, year-to-date, it has declined by 6.72%, contrasting with the Sensex's gain of 5.05%. Over the last three years, Alembic's performance of 31.23% lags behind the Sensex's 51.10% increase.